Trially AI

📍 Kansas City, United States🗓 Founded 2023👥 14 employees💰 Last funded Aug 2025
Software Development🌐 trially.ai
Website LinkedIn
Trially is shaping the future of clinical trial recruitment through its HIPAA-compliant AI technology. Powered by Large Language Models (LLMs), Trially safely unlocks rich medical data to help life science leaders enroll patients at breakthrough speed. Loved by customers, Trially fills trials faster—with 2-6x increase in enrollment rate, 73% fewer screen fails, and 90% less time spent on EMR chart reviews. Trially’s site-based software rapidly prescreens patients from any clinical data source, fully compliant with HIPAA, SOC 2, FDA 21 CFR Part 11, and ISO 27001. Designed to meet the needs of Physicians, Sites, Sponsors and CROs, Trially AI empowers you to achieve outstanding results in clinical research.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Trially AI?
Trially AI has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Trially AI last raise funding?
The most recent investment in Trially AI recorded on gritt.io was in August 2025.
When was Trially AI founded?
Trially AI was founded in 2023.
What industry is Trially AI in?
Trially AI operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Trially AI based?
Trially AI is headquartered in Kansas City, United States.